HCA

HCA Healthcare, Inc.

Healthcare · $93.1B market cap

Verdict

Share price

$426.69

close of Oct 3, 2026

Fair value

$458.55

Sticker Price

Payback Price

$183.42

buy price

Fairly Valued

HCA is Fairly Valued: at $426.69 it's within 7% of its fair value of $458.55. Its buy price (Payback Price) is $183.42, 57% below today's price. Business quality is mixed: 2 of 5 key numbers clear the 10% bar.

How we valued it

Free Cash Flow. Sales grew 8% a year over the last 3 years, below the 15% we look for in a fast grower, so we value it on its free cash flow instead of an earnings forecast.

Business quality

2 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth12.8% a year✓
Equity per share growth—?
Sales growth5.8% a year✗
Free cash flow growth9.3% a year✗
Return on invested capital17.2%✓

Follow HCA

Get notified when it reaches its buy price of $183.42. Free.

Create a free account

Superinvestors

5 of the investors we track hold HCA. In Q2 2026, 1 added and 1 sold out. Who we track

Moves in Q2 2026

Added: Glenn Greenberg

Sold out: Viking Global Investors

Insider activity

Since Aug 26, 2026: no open-market purchases and 1 other filing (stock awards, tax withholding and similar). Why purchases matter

Other filings

About HCA Healthcare, Inc.

HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medical and surgical care, encompassing inpatient services, intensive care, cardiac treatment, diagnostic procedures, and emergency services. These hospitals additionally…

Medical - Care Facilities

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works